| Imaging Biomarkers for Immune Checkpoint Inhibitor Treatment in Patients With Non-small Cell Lung Cancer (NCT05260606) | Samsung Medical Center | 2022-05-09 |
| Tislelizumab and Radiotherapy for Recurrent Cervical Cancer (NCT05310383) | Lei Li | 2022-03-27 |
| PD-1 Antibody and Radiotherapy for Recurrent Cervical Cancer (NCT05310305) | Lei Li | 2022-03-26 |
| Fecal Microbiota Transplantation in Patients With Malignancies Not Responding to Cancer Immunotherapy (NCT05273255) | Michael Scharl | 2022-03-14 |
| Immunotherapy for Recurrent Cervical Cancer Refractory to Platinum-based Chemotherapy: Multi-Center Trial (NCT05290935) | Lei Li | 2022-03-13 |
| Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population (NCT05863052) | University of Oklahoma | 2022-01-31 |
| irAE Prediction of Anti-PD-1/L1 in Lung Cancer (NCT05288569) | Peking Union Medical College Hospital | 2022-01-21 |
| Safety of SBRT With Anti-PD1 and Anti-IL-8 for the Treatment of Multiple Metastases in Advanced Solid Tumors and Melanoma (NCT04572451) | Yana Najjar | 2021-11-29 |
| A Perspective, Self-control Study on the Progression of Carotid Plaques in Anti-PD-1 mAb Treated Tumor Patients by Artery Ultrasound Follow-up (NCT05123287) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2021-10-08 |
| Identification of Predictive Biomarkers for Immune-Related Adverse Events (irAEs) in Patients Undergoing Immune CheckPoint Inhibitors (ICPI) Treatment (NCT05813418) | Centre Hospitalier Universitaire, Amiens | 2021-07-02 |
| Relationship Between Immunity and Metabolism in Patients Receiving Immune Checkpoint Inhibitors for Advanced Cancer. ( RIMEC ) (NCT04808817) | Assistance Publique - Hôpitaux de Paris | 2021-05-10 |
| A Study of Camrelizumab Combined Apatinib in Hepatocellular Carcinoma Previously Treated With Immune Checkpoint Inhibitors (ICIs). (NCT04826406) | Hunan Cancer Hospital | 2021-02-03 |
| Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced Cancer (NCT04670445) | Massachusetts General Hospital | 2021-01-23 |
| Assessment of Myocardial Injury in Patients Treated With Immune Checkpoint Inhibitors (NCT05349058) | Flinders University | 2021-01-17 |
| COVICI-SURV: COVID-19 Vaccination Around ICI Start and Survival (NCT07729241) | Groupe Hospitalier Pitie-Salpetriere | 2020-12-28 |
| The Associations of Psychological Stress With Therapy Efficacy and Prognosis of Lung Cancer (STRESS-LUNG) (NCT05477979) | Second Xiangya Hospital of Central South University | 2020-06-01 |
| A Clinical Study on the Analysis of Risk Factors for the Occurrence of PD-1/PD-L1 Inhibitor-associated Liver Injury in Lung Cancer Patients (NCT06402981) | Zhejiang University | 2020-01-01 |
| Impact of Therapeutic Patient Education on the Toxicity of Immune Checkpoint Inhibitors in Oncology (NCT03948724) | Institut Cancerologie de l'Ouest | 2019-12-11 |
| Organ-Specific Differences in Immunotherapy Response Among Metastatic Cancer Patients (NCT07631611) | Wenlong Zhong, MD | 2016-01-01 |